Ultragenyx Pharmaceutical (RARE) Q2 2021 Earnings

4MayConfirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-2.03
-1.22
-0.4
0.41

Details

Expected EPS
-1.33
Actual EPS
-2.03
Surprise EPS
-0.7
Surprise Percent
+52.63%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.03 per share for Q2 2021.

0 Comments

Share your thoughts